Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19

This publication has 10 references indexed in Scilit:

• Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
  International Journal of Molecular Sciences, 2020
• Does Ibuprofen Worsen COVID-19?
  Drug Safety, 2020
• The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
  European Journal of Internal Medicine, 2020
• Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
  New England Journal of Medicine, 2020
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  Cell, 2020
• Clinical Relevance and Role of Neuronal AT ₁ Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension
  Circulation Research, 2017
• Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
  Hypertension, 2014
• EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer
  Prostate Cancer and Prostatic Diseases, 2013
• TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
  Antiviral Research, 2010
• Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II–Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats
  Hypertension, 2005